Aiwu Ruth He, MD, PhD, Discusses 3-Year Survival Data for Durvalumab Plus Chemo in Biliary Tract Cancer, Other Advances
This interview will appear in the June issue of Evidence-Based Oncology.
United States Astrazeneca Daiichi Sanyko Shubh Goel Van Custem American Cancer Society Astrazeneca Pharmaceuticals
Source: ajmc.com